Unless phytonutrients can be “converted into new chemical entities for which more specific medical claims are possible,” the development of these plants seems unlikely.Sure, they’re “extensively exploited as active ingredients of innumerable products on ill-regulated food supplement markets,” but apart from this, “progress through clinical trials” remains sluggish.